1. Home
  2. IH vs FATE Comparison

IH vs FATE Comparison

Compare IH & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IH
  • FATE
  • Stock Information
  • Founded
  • IH 1996
  • FATE 2007
  • Country
  • IH China
  • FATE United States
  • Employees
  • IH N/A
  • FATE N/A
  • Industry
  • IH Other Consumer Services
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IH Real Estate
  • FATE Health Care
  • Exchange
  • IH Nasdaq
  • FATE Nasdaq
  • Market Cap
  • IH 151.5M
  • FATE 130.7M
  • IPO Year
  • IH 2020
  • FATE 2013
  • Fundamental
  • Price
  • IH $2.98
  • FATE $1.07
  • Analyst Decision
  • IH
  • FATE Hold
  • Analyst Count
  • IH 0
  • FATE 7
  • Target Price
  • IH N/A
  • FATE $3.83
  • AVG Volume (30 Days)
  • IH 64.7K
  • FATE 1.4M
  • Earning Date
  • IH 09-26-2025
  • FATE 08-12-2025
  • Dividend Yield
  • IH 2.88%
  • FATE N/A
  • EPS Growth
  • IH N/A
  • FATE N/A
  • EPS
  • IH 0.26
  • FATE N/A
  • Revenue
  • IH $123,701,096.00
  • FATE $13,335,000.00
  • Revenue This Year
  • IH $39.02
  • FATE N/A
  • Revenue Next Year
  • IH N/A
  • FATE N/A
  • P/E Ratio
  • IH $11.26
  • FATE N/A
  • Revenue Growth
  • IH N/A
  • FATE 105.85
  • 52 Week Low
  • IH $1.47
  • FATE $0.66
  • 52 Week High
  • IH $3.60
  • FATE $5.49
  • Technical
  • Relative Strength Index (RSI)
  • IH 58.94
  • FATE 40.63
  • Support Level
  • IH $2.86
  • FATE $1.19
  • Resistance Level
  • IH $3.07
  • FATE $1.35
  • Average True Range (ATR)
  • IH 0.29
  • FATE 0.08
  • MACD
  • IH 0.01
  • FATE -0.01
  • Stochastic Oscillator
  • IH 55.07
  • FATE 3.45

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: